Mortality Trends of Gastrointestinal, Liver, and Pancreaticobiliary Diseases: A Hospital-Based Prospective Study in the Southeast of Iran
-
Published:2022-10-30
Issue:4
Volume:14
Page:404-409
-
ISSN:2008-5249
-
Container-title:Middle East Journal of Digestive Diseases
-
language:en
-
Short-container-title:Middle East J Dig Dis
Author:
Zahedi Mohammad Javad1, Shafieipour Sara2, Hayatbakhsh Abbasi Mohammad Mahdi1, Nakhaie Mohsen1, Rezaei Zadeh Rukerd Mohammad1, Lashkarizadeh Mohammad Mehdi3, Noorbini Farbood4, Baghaei Mohammad Hasan1, Pourjafari Abbas1, Aminian Ebrahim1, Karami Robati Fatemeh5, Dehghani Azam5
Affiliation:
1. Gastroenterology and Hepatology Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran 2. Physiology Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran 3. Colorectal Research Center, Shiraz University of Medical Sciences, Shiraz, Iran 4. Department of Internal Medicine, School of Medical Sciences, Azad University, Shahroud, Iran 5. Clinical Research Development Unit, Afzalipour Hospital, Kerman University of Medical Sciences, Kerman, Iran
Abstract
Background: Gastrointestinal (GI), liver, and pancreaticobiliary diseases, in addition to the high health care utilization, account for a significant proportion of disability and death in Iran. We aimed to assess the incidence of in-hospital mortality for the total GI, liver, and pancreaticobiliary diseases in all hospitals in Kerman, Iran. Methods: In a cross-sectional study from May 2017 to April 2018, we collected the data of in-hospital death records due to GI, liver, and pancreaticobiliary diseases in all hospitals in Kerman city. GI and liver diseases were classified into three main categories: 1. Non-malignant GI diseases, 2. Non-malignant liver and pancreaticobiliary diseases, and 3. GI, liver, and pancreaticobiliary malignancies. All data were analyzed using SPSS software, version 22 (IBM). Results: Of 3427 in-hospital mortality, 269 (7.84%) deaths were due to GI, liver, and pancreaticobiliary diseases, of which 82 (30.48%) were related to non-malignant GI disorders, 92 (34.20%) to the non-malignant liver and pancreaticobiliary diseases, and 95 (35.31%) were associated with GI, liver and pancreaticobiliary malignancies. Most patients were male (62.08%), and the most common age was between 60-80 years (40.5%). GI bleeding occurred in 158 (58.73%) patients, and variceal bleeding was the most common cause (28.48%). Additionally, cirrhosis was reported in 41 out of 92 (44.56%), and hepatitis B virus (HBV) was the most common cause of cirrhosis among 17 out of 41 (41.46%). Conclusion: Our results show that gastric, colorectal, and pancreatic cancers and cirrhosis due to HBV were the most common causes of mortality associated with GI, liver, and pancreaticobiliary diseases in the hospitals of Kerman.
Publisher
Maad Rayan Publishing Company
Subject
Gastroenterology,Hepatology
Reference29 articles.
1. Burden of gastrointestinal and liver diseases in Iran: estimates based on the global burden of disease, injuries, and risk factors study, 2010;Malekzadeh F;Middle East J Dig Dis,2015 2. Peery AF, Crockett SD, Murphy CC, Lund JL, Dellon ES, Williams JL, et al. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2018. Gastroenterology 2019;156(1):254-72.e11. doi: 10.1053/j.gastro.2018.08.063. 3. Digestive and liver diseases statistics, 2004 4. Survey of digestive health across Europe: Final report. Part 1: The burden of gastrointestinal diseases and the organisation and delivery of gastroenterology services across Europe 5. Gastrointestinal disease burden and mortality: A public hospital-based study from 2005 to 2014
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|